News

Teva Pharmaceutical Industries Ltd. officer Mark Sabag filed a Form 4 on November 6, 2026, disclosing the exercise of 46,000 stock options and the same-day sale of 46,000 ordinary shares on November 5, 2026.

NIO Inc. director Wu Hai (Hector) filed a Form 4 on November 6, 2026, disclosing the vesting of 85,803 restricted share units and the resulting acquisition of an equal number of American depositary shares at a price of $0.

Charles R. Corbin Jr., Senior Executive Vice President, General Counsel and Corporate Operations, and Secretary of Hilton Grand Vacations Inc., filed a Form 4 on November 6, 2026, disclosing option exercises and open-market sales of common stock that occurred on November 4, 2026.

NIO Inc. director Annabelle Yu Long filed a Form 4 on November 6, 2026, reporting the vesting of 85,803 restricted share units and the resulting acquisition of 85,803 American depositary shares at a price of $0.

NIO Inc. director Wen Yonggang filed a Form 4 on November 6, 2026, disclosing the vesting of 78,003 restricted share units and the acquisition of an equal number of American depositary shares at a price of $0.

Flywire Corp Chief Financial Officer Cosmin Pitigoi filed a Form 4 on November 6, 2026, disclosing the sale of 20,532 shares of Voting Common Stock on November 4, 2026, executed under a previously adopted Rule 10b5-1 trading plan.

Flywire Corp Chief Payments Officer Mohit Kansal filed a Form 4 on November 6, 2026, disclosing the sale of 6,053 shares of Voting Common Stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.